Cita APA

Kaufman, H. L., Russell, J. S., Hamid, O., Bhatia, S., Terheyden, P., D’Angelo, S. P., . . . Nghiem, P. (2018). Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. J Immunother Cancer.

Chicago Style Citation

Kaufman, Howard L., et al. "Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 year of Follow-up: JAVELIN Merkel 200, a Phase 2 Clinical Trial." J Immunother Cancer 2018.

Cita MLA

Kaufman, Howard L., et al. "Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 year of Follow-up: JAVELIN Merkel 200, a Phase 2 Clinical Trial." J Immunother Cancer 2018.